Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Bedimo

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: InfliximabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: VilobelimabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: AbataceptNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical IllnessAdarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in AdultsAmy Hirsch Shumaker, Adarsh Bhimraj, Roger Bedimo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. TocilizumabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Annals of Internal Medicine|September 30, 2024
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons LearnedRoy M Gulick, Alice K Pau, Eric Daar, et al.
Annals of Internal Medicine|June 14, 2021
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19Safia Kuriakose, Kanal Singh, Alice K Pau, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: InfliximabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: VilobelimabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: AbataceptNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical IllnessAdarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in AdultsAmy Hirsch Shumaker, Adarsh Bhimraj, Roger Bedimo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. TocilizumabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Annals of Internal Medicine|September 30, 2024
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons LearnedRoy M Gulick, Alice K Pau, Eric Daar, et al.
Annals of Internal Medicine|June 14, 2021
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19Safia Kuriakose, Kanal Singh, Alice K Pau, et al.
Pageof 9